Skip to main content

Table 1 Patients prescribed each medication for those with CVD/HF and/or CKD and those without

From: Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: a cross-sectional study

 

CVD/HF and/or CKD

No CVD/HF/CKD

Total N with medication prescribed

Medication

N (% of comorbidity group)

 

 SGLT2i*

161 (14.9)

701 (21.2)

862

 GLP-1RA*

50 (4.6)

363 (11.0)

413

 Metformin/Biguanide

828 (76.8)

2573 (78.0)

3401

 Insulin secretagogues*

304 (28.2)

729 (22.1)

1033

 DPP4i*

240 (22.3)

603 (18.3)

843

 Insulin*

330 (30.6)

747 (22.6)

1077

Total in comorbidity group

1078

3299

4377

  1. Used to indicate a significant difference between both comorbidity groups at p < 0.05